A Novel Strategy For Absolute Quantitation Of Human Proteins Vincent R. Richard(1), Robert Popp(2), Rene Zahedi(3-6), Yassene Mohammed(1,7), Christoph H. Borchers(1,8-10*) (1). Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, QC H3T 1E2, Canada; (2). MRM Proteomics Inc, Montreal, QC H2X 1Y4, Canada; (3). Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB R3E 3P4, Canada; (4). Department of Internal Medicine, University of Manitoba, Winnipeg, MB R3E 3P4 , Canada; (5). Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; (6). CancerCare Manitoba Research Institute, Winnipeg, MB R3E 0V9, Canada; (7). Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; (8). Gerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada; (9). Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada; (10). Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada; *…presenting author Christoph Borchers, PhD (Presenter) Jewish General Hospital, McGill University Montreal, QC, Canada Presenter Bio: Dr. Christoph Borchers is recognized as a pioneer and leading figure in the development of mass spectrometry-based methods for protein quantification using Multiple Reaction Monitoring (MRM). He has also published more than 300 peer-reviewed papers in scientific journals, and is the founder and director of the McGill-Lady Davis Institute Integrated Proteomics Program at the Jewish General Hospital, McGill University, where he is currently a full professor in the Department of Oncology. His research is centred around the improvement, development, and application of proteomics and metabolomics technologies, with a major focus on quantitative targeted proteomics for clinical diagnostics, as well as new mass-spectrometry-based techniques for structural proteomics. Dr. Borchers received his BS, MSc, and PhD degrees from the University of Konstanz, Germany in 1996. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he became the director of the Duke–UNC Proteomics Facility and held a faculty position at the UNC Medical School in Chapel Hill, NC (2001-2006). From 2006 to 2019, he was a Professor in the Department of Biochemistry and Microbiology, and Director of the University-Genome British Columbia Proteomics Centre at the University of Victoria, British Columbia, Canada, where he held the Rix BC Leadership Chair in Biomedical and Environmental Proteomics. Dr. Borchers is also involved in promoting proteomics research and education through his involvement with HUPO (International Council Member), the British Columbia Proteomics Network (Executive Committee Member, past Scientific Director) and the Canadian National Proteomics Network (Member, past VP External and Chair of the Board of Directors). He is also a Fellow of the Canadian Academy of Health Sciences.